Risk Factors of Mortality After Liver Transplantation in Uruguay

Transplant Proc. 2018 Mar;50(2):499-502. doi: 10.1016/j.transproceed.2017.12.036.

Abstract

Introduction: Identification of predictive factors of mortality in a liver transplant (LT) program optimizes patient selection and allocation of organs.

Objective: To determine survival rates and predictive factors of mortality after LT in the National Liver Transplant Program of Uruguay.

Methods: A retrospective study was conducted analyzing data prospectively collected into a multidisciplinary database. All patients transplanted since the beginning of the program on July 2009 to April 2017 were included (n = 148). Twenty-nine factors were analyzed through the univariate Kaplan-Meier model. A Cox regression model was used in the multivariate analysis to identify the independent prognostic factors for survival.

Results: Overall survival was 92%, 87%, and 78% at discharge, 1 year, and 3 years, respectively. The Kaplan-Meier survival curves were significantly lower in: recipients aged >60 years, Model for End-Stage Liver Disease score >21, LT due to hepatocellular carcinoma (HCC) and acute liver failure (ALF), donors with comorbidities, intraoperative blood loss beyond the median (>2350 mL), red blood cell transfusion requirement beyond the median (>1254 mL), intraoperative complications, delay of extubation, invasive bacterial, and fungal infection after LT and stay in critical care unit >4 days. The Cox regression model (likelihood ratio test, P = 1.976 e-06) identified the following independent prognostic factors for survival: LT for HCC (hazard ratio [HR] 4.511; P = .001) and ALF (HR 6.346; P = .004), donors with comorbidities (HR 2.354; P = .041), intraoperative complications (HR 2.707; P = .027), and invasive fungal infections (HR 3.281; P = .025).

Conclusion: The survival rates of LT patients as well as the mortality-associated factors are similar to those reported in the international literature.

MeSH terms

  • Adult
  • Carcinoma, Hepatocellular / complications
  • Carcinoma, Hepatocellular / surgery
  • End Stage Liver Disease / etiology
  • End Stage Liver Disease / surgery*
  • Female
  • Humans
  • Kaplan-Meier Estimate
  • Liver Failure, Acute / complications
  • Liver Failure, Acute / surgery
  • Liver Neoplasms / complications
  • Liver Neoplasms / surgery
  • Liver Transplantation / adverse effects
  • Liver Transplantation / mortality*
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Patient Selection
  • Proportional Hazards Models
  • Retrospective Studies
  • Risk Factors
  • Severity of Illness Index
  • Survival Rate
  • Uruguay / epidemiology